Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib

MLA

Lisbeth Enggaard, et al. “Real-World Outcomes for 205 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.” European Journal of HaematologyREFERENCES, vol. 105, no. 5, June 2020. EBSCOhost, https://doi.org/10.1111/ejh.13499.

APA

Lisbeth Enggaard, Emelie Curovic Rotbain, Rasmus Heje Thomsen, Mikael Frederiksen, Robert Schou Pedersen, Michael Asger Andersen, Tine Bjørn Nielsen, Ilse Christiansen, Olav J. Bergmann, Carsten Utoft Niemann, Henrik Frederiksen, & Kathrine Aarup. (2020). Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib. European Journal of HaematologyREFERENCES, 105(5). https://doi.org/10.1111/ejh.13499

Chicago

Lisbeth Enggaard, Emelie Curovic Rotbain, Rasmus Heje Thomsen, Mikael Frederiksen, Robert Schou Pedersen, Michael Asger Andersen, Tine Bjørn Nielsen, et al. 2020. “Real-World Outcomes for 205 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.” European Journal of HaematologyREFERENCES 105 (5). doi:10.1111/ejh.13499.